Jury to Decide: Were Shkreli’s Gambles to Save His Drug Company Criminal?<br />Evan Greebel, a lawyer who worked for Mr. Shkreli, emailed him about the shares: “I’m listing<br />everyone’s addresses as c/o msmb…does that work for you?” Mr. Shkreli replied: “no!<br />“If Retrophin doesn’t raise $1m in the near future, I think you know what the result will be.”<br />Then Mr. Shkreli called Mr. Pierotti, “screaming and yelling,” Mr. Pierotti testified.<br />“I have been extremely stressed about Retrophin; the declining stock price is particularly alarming,” Mr. Shkreli wrote.<br />Suddenly, in September 2012, Mr. Shkreli emailed investors<br />that he was shutting down MSMB Capital and MSMB Healthcare to focus on Retrophin and that they could cash out.<br />The price of the shell company Retrophin was buying had suddenly gone up, Mr. Shkreli told an investor.
